0.410 CD

- (-%)
Range 0.405 - 0.410   (1.23%)
Open 0.410
Previous Close 0.410
Buy Price 0.400
Buy Volume 1.2
Sell Price 0.410
Sell Volume 83.4
Volume 16.7
Value 6,846
Remark CD
Measurement Type Value
EPS (SGD) 0.054
Trailing EPS (SGD) 0.051
NAV (SGD) 0.058
Cash In Hand (SGD) 0.047
Dividend 0.04
Dividend Yield (%) 8.081
PE 9.213
Trailing PE 9.644
Price / NAV 8.476
Price / Cash In Hand 10.487
Issued & Paid-up Shares 148,892,000
Treasury Shares 2,503,000
Market Cap (M) 73.702
Par Value (SGD) n.a.
Beta - 75 Days 0.233
R-Squared - 75 Days(%) 1.12
Beta - 500 Days 0.391
R-Squared - 500 Days(%) 1.98
ISIN Code SG1DC2000004
Under CPF Investment Scheme (CPFIS) No
Index Components FTSE ST Catalist Index
Delayed prices. Updated at 28 Sep 2022 17:16.
Data powered by

Upcoming Events

Dividend

Ex-Date 31 Oct 2022
Record Date 01 Nov 2022
Payable Date 11 Nov 2022
Rate: SGD 0.012 Per Security
Data powered by SGX.
View All Events

About HC Surgical

HC Surgical Specialists Limited and its subsidiaries are engaged in the medical services business. The Company is engaged in the provision of endoscopic procedures, including gastroscopies and colonoscopies, and general surgery services with a focus on colorectal procedures across a network of clinics located throughout Singapore. It is engaged in providing medical care, consultancy, treatment and surgery in the field of colorectal endoscopy, vein and vascular. Its clinics are equipped with the facilities needed to perform a range of procedures on-site, including endoscopic procedures and other minor surgical services. The Company treats a range of conditions, including hemorrhoids, anal abscesses, anal fissures, gallstones and inflammation of the gallbladder, hernias, colorectal cancer, stomach cancer, colonic diverticular disease, and cysts and lipomas. The Company's clinics are located in central Singapore, as well as, in residential areas, including the heartlands.

Loading Chart...